Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN114409558A reveals a high-yield aqueous synthesis for Sacubitril intermediates. Discover cost-effective, scalable manufacturing solutions for complex pharmaceutical intermediates.
Novel patent CN106916074A offers high-purity Tomoxetine Hydrochloride synthesis with recyclable solvents and reduced environmental impact for reliable supply.
Novel silver-catalyzed route for Jaspine B isomer synthesis. Reduces cost and improves supply chain reliability for global pharmaceutical intermediates manufacturing.
Novel 7-step synthesis for rosuvastatin calcium intermediates. High yield, mild conditions, cost-effective manufacturing for global supply chains.
Patent CN118871420A reveals efficient codeine synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN103288650A details a high-yield Memantine synthesis using phosphoric acid catalysis, offering significant cost reduction in pharmaceutical manufacturing and scalable supply chain solutions.
Advanced photocatalytic synthesis for high-purity 1-aryl cyclopropyl phosphonate intermediates. Delivers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel amide intermediate process for HMG-CoA inhibitors. Mild conditions, high purity, scalable manufacturing for global pharma supply chains.
Patent CN104086392A reveals a water-based Suzuki coupling for Felbinac. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel nitrilase mutant enhances acetophenone acid production efficiency. Sustainable biocatalysis solution for reliable pharmaceutical intermediate supply chain optimization.
Novel patent CN103739537B details stable Ezetimibe synthesis. Offers high yield and scalability for pharmaceutical intermediates supply chain efficiency.
Discover a novel Ezetimibe synthesis method using titanium Lewis acids. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable routes.
Patent CN116496171A details a novel reductive amination route for Iohexol, eliminating genotoxic impurities and ensuring high-purity pharmaceutical intermediates supply.
Novel 7-step route for Rosuvastatin calcium intermediate using vinyl chloride. Cost-effective, scalable, high purity manufacturing solution.
Advanced synthesis of Eliglustat intermediates via patent CN110461826B. Offers high purity, scalable routes for pharmaceutical supply chains with reduced operational complexity.
Novel acid-activation route for Donepezil intermediates offers 82% total yield. Discover cost-effective, scalable API manufacturing solutions.
Patent CN113429328A details a low-cost tartaric acid resolution method for chiral fluorinated pyrrolidines, enabling scalable API intermediate production.
Advanced synthesis route for high-purity antibiotic intermediates. Improves yield and stability via novel mother liquor recycling technology.
Patent CN111909156B reveals a high-yield, green synthesis for Olatinib Maleate. Discover cost reduction in pharmaceutical manufacturing and scalable supply solutions.
Novel solid-liquid combination method for Exenatide reduces purification difficulty and enhances supply chain reliability for pharmaceutical manufacturing partners globally.